Citi: Maintains Xenon Pharmaceuticals (XENE.US) rating, adjusted from buy to buy rating, and adjusted the target price from $62.00 to $60.00.
花旗：维持Xenon Pharmaceuticals(XENE.US)评级，由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。
Citi: Maintains Xenon Pharmaceuticals (XENE.US) rating, adjusted from buy to buy rating, and adjusted the target price from $62.00 to $60.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated